Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SMART-I: SiroMax™ Multi-Center Coronary Artery Lesion Treatment - Safety and Feasibility Study of SiroMax SCB in ISR and DNSV

NCT07811024 is registered in ClinicalTrials.gov with Tonic Medical, Inc. as lead sponsor.

NCT NCT07811024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07811024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SMART-I: SiroMax™ Multi-Center Coronary Artery Lesion Treatment - Safety and Feasibility Study of SiroMax SCB in ISR and DNSV
Lead sponsor
Tonic Medical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 12, 2026
Completion date
May 31, 2032
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cad, cad - coronary artery disease, cad patients, coronary artery disease, coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd)), in-stent restenosis or de novo coronary artery lesions, in-stent stenosis (restenosis) of coronary artery stent, pci, ptca, small vessel disease, stenosis artery, stenosis coronary, stenotic coronary lesion